Sept 28 (Reuters) - Theratechnologies Inc TH.TO
* Theratechnologies to move forward with development of new single vial formulation for EGRIFTA(R)(Tesamorelin for injection) Source text for Eikon: ID:nCCND5tnH Further company coverage: TH.TO
Sept 28 (Reuters) - Theratechnologies Inc TH.TO
* Theratechnologies to move forward with development of new single vial formulation for EGRIFTA(R)(Tesamorelin for injection) Source text for Eikon: ID:nCCND5tnH Further company coverage: TH.TO